DiamiR Biosciences Announces Participation in Alzheimer’s Panel at the BioFuture 2022 Conference

NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Nov. 7, 2022 /PRNewswire/ — DiamiR, a developer of modern blood-based diagnostic checks for mind well being and different illnesses, right this moment introduced that the corporate’s administration will take part within the BioFuture Conference being held on November 7-9, 2022 on the Lotte New York Palace in New York City, NY.

Kira Sheinerman, Ph.D., Co-Founder and Executive Director, might be a participant within the panel dialogue, “New approvals, new approaches, new diagnostics, and might we actually reverse the development of AD?” at 10:30 am EST on Wednesday, November 9^th in Holmes I. The panel dialogue will deal with the position of latest diagnostics instruments and novel therapeutics in revolutionizing look after Alzheimer’s sufferers.

“We consider that blood-based diagnostics will assist recruit higher outlined contributors into scientific trials and also will enable environment friendly monitoring of Alzheimer’s sufferers, leading to improved outcomes,” mentioned Alidad Mireskandari, Ph.D., MBA, firm’s Chief Executive Officer. “We are excited to have Kira share our imaginative and prescient on how growing new diagnostic instruments can positively affect the lives of Alzheimer’s sufferers.”

Management may also be obtainable for one-on-one conferences. If you wish to request a gathering, please register at https://biofuture.com/biofuture-registration/.

About DiamiR

DiamiR is a privately held molecular diagnostics firm targeted on growing minimally invasive checks for detection and monitoring of pathology based mostly on quantitative evaluation of organ-enriched microRNA signatures in plasma for screening, affected person stratification, in addition to illness development and therapy monitoring. DiamiR collaborates with main educational facilities, illness foundations, and biopharma corporations. For extra info, please go to the corporate’s web site at www.diamirbio.com.

This information launch comprises forward-looking statements relating to future occasions. These statements are predictions and are topic to dangers and uncertainties that would trigger the precise occasions or outcomes to vary materially.

Contact:
Alidad Mireskandari PhD
203-570-8275
amireskandari@diamirbio.com